Ophthalmic Pharmaceutical Pipeline*
Our single focus in ophthalmology enables exploration of novel therapies in dry eye, glaucoma,
uveitis, and wet AMD—therapies determined to challenge eye disease, one patient at a time
WET AGE-RELATED MACULAR DEGENERATION
DRY EYE & CORNEAL DISORDERS
*Santen does not disclose early research activities. These are compounds in Development and are not for sale.